OMDA AS – NOTICE OF ORDINARY GENERAL MEETING

Oslo, Norway, 9 april 2026: The Board of Directors (the “Board”) hereby calls for the annual general meeting of Omda AS (the “Company”) to be held at the Company’s offices in Drammensveien 288, 0283 Oslo, at 14:00 CEST on 28 April 2026.

The agenda includes: • Approval and adoption of the annual accounts and directors’ report for 2025, including the Board of Directors’ proposal for distribution of dividends • Election of members to the Board of Directors • Election of members to the Nomination and Remuneration Committee • Approval of remuneration to the Board of Directors • Approval of remuneration to the Nomination and Remuneration Committee • Approval of remuneration to the Company’s auditor • Approval of articles of association for the Nomination and Remuneration Committee • Granting of a power of attorney to the Board of Directors to acquire the Company’s own shares

The Board encourages all shareholders to submit proxy forms prior to the meeting as an alternative to attending the meeting in person. Shareholders may cast their votes by using the proxy form with advance voting, as included in the Notice to the Annual General Meeting. The documents will be distributed to all registered shareholders and are available on omda.com.

For more information, please contact: Einar Bonnevie Chief Financial Officer +47 91 55 45 32 einar.bonnevie@omda.com

About Omda Omda is the leading provider of niche software for specialised healthcare and emergency services in the Nordics with a growing presence in Europe, North America and the Pacific region. The company has more than 750 contracts in 25 countries and employs approximately 260 dedicated specialists. Our highly specialised healthcare solutions empower medical professionals and emergency responders, enabling them to know more and work smarter. With a focus on user-centric design, value-driven development and close working relationships with customers, Omda delivers solutions that enhance patient safety and improve healthcare outcomes.

For more information, visit www.omda.com Follow us on LinkedIn